Pituitary adenoma in patients with multiple endocrine neoplasia type 1 - a cohort study.

Date publication

octobre 2021

Journal

European journal of endocrinology

Auteurs

Membres identifiés du Cancéropôle Est :
Dr GOUDET Pierre , Pr VERGES Bruno

Tous les auteurs :
Le Bras M, Leclerc H, Rousseau O, Goudet P, Cuny T, Castinetti F, Bauters C, Chanson P, Tabarin A, Gaujoux S, Christin-Maitre S, Ruszniewski P, Borson-Chazot F, Guilhem I, Caron P, Goichot B, Beckers A, Delemer B, Raingeard I, Vergès B, Smati S, Wargny M, Cariou B, Hadjadj S

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/34636744

Résumé

Pituitary adenoma (PA) is one of the three major components of multiple endocrine neoplasia type 1 (MEN1). Recent studies have suggested that MEN1-associated PAs are less aggressive than initially estimated. We propose an analysis of the outcome of PAs with standard of care treatment in a nationwide cohort of MEN1 patients.

Référence

Eur J Endocrinol. 2021 Oct 1;: